Unknown

Dataset Information

0

Design, Synthesis and Phenotypic Profiling of Simplified Gedatolisib Analogues.


ABSTRACT: Targeted antitumour therapy has revolutionized the treatment of several types of tumours. Among the validated targets, phosphatidylinositol-3 kinase (PI3K) deserves to be highlighted. Several PI3K inhibitors have been developed for the treatment of cancer, including gedatolisib (4). This inhibitor was elected as a prototype and molecular modifications were planned to design a new series of simplified gedatolisib analogues (5a-f). The analogues were synthesised, and the comparative cytotoxic activity profile was studied in phenotypic models employing solid and nonadherent tumour cell lines. Compound 5f (LASSBio-2252) stood out as the most promising of the series, showing good aqueous solubility (42.38 μM (pH = 7.4); 39.33 μM (pH = 5.8)), good partition coefficient (cLogP = 2.96), cytotoxic activity on human leukemia cell lines (CCRF-CEM, K562 and MOLT-4) and an excellent metabolic stability profile in rat liver microsomes (t1/2 = 462 min; Clapp = 0.058 mL/min/g). The ability of 5f to exert its cytotoxic effect through modulation of the PI3K pathway was demonstrated by flow cytometry analysis in a comparative manner to gedatolisib.

SUBMITTER: Costa CMX 

PROVIDER: S-EPMC9964390 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications


Targeted antitumour therapy has revolutionized the treatment of several types of tumours. Among the validated targets, phosphatidylinositol-3 kinase (PI3K) deserves to be highlighted. Several PI3K inhibitors have been developed for the treatment of cancer, including gedatolisib (<b>4</b>). This inhibitor was elected as a prototype and molecular modifications were planned to design a new series of simplified gedatolisib analogues (<b>5a-f</b>). The analogues were synthesised, and the comparative  ...[more]

Similar Datasets

| S-EPMC7687248 | biostudies-literature
| S-EPMC2791795 | biostudies-literature
| S-EPMC7496434 | biostudies-literature
| S-EPMC5346982 | biostudies-literature
| S-EPMC3807767 | biostudies-literature
| S-EPMC10749478 | biostudies-literature
| S-EPMC6269118 | biostudies-literature
| S-EPMC11357204 | biostudies-literature
| S-EPMC6072509 | biostudies-literature
| S-EPMC3627542 | biostudies-literature